In The News

Global pharma firms interested in local startup's new glaucoma treatment

Singapore"FIRST you have my interest, now you have my attention."And that is what local biotech startup Peregrine Ophthalmic managed to do, in the words of associate professor Tina Wong, who was describing how a new glaucoma drug delivery solution developed by her 15-month-old startup has attracted inquiries from the world's top five pharmaceutical companies.Not a bad start for the company...


US biotech giant Amgen opens $200m plant in Tuas

AMERICAN pharmaceutical giant Amgen officially opened a $200 million biomanufacturing facility in Tuas yesterday. The 120,000 sq ft plant, the company's first manufacturing site in Asia, will produce a drug substance used to treat osteoporosis and bone-related disorders in cancer patients. Amgen plans to start building a second facility next door by the middle of next year. This plant will make...


Scientists develop tiny particle to aid cancer fight

SCIENTISTS in Singapore have developed a tiny particle, 10,000 times smaller than a grain of sand, that can detect signalling molecules in tumour cells, penetrate them and potentially release drugs to kill them. The particles are small enough to enter tumours. Once inside, a chemical coating on the particle interacts with other chemicals used by tumour cells to communicate with each other. This...


More news...

Events |

More
 

BioPharma Asia Convention 2015

The BioPharma Asia Convention is the leading industry platform for pharmas, biotechs, CMOs, CROs and investors to assemble and assess the latest trends, source for new partnerships as well shop for new solutions and technology. Taking place in Singapore, 23-26 March 2015
More events...